C. O. Truxton Recalls Mislabeled Amitriptyline HCL Tablets
C. O. Truxton is recalling specific lots of Amitriptyline HCL 50 mg tablets due to potential label mixups. The recall is nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to a labeling error (label mixup). Per the rubric, minor labeling errors and voluntary precautionary recalls without reported injuries fall under the Moderate severity level.
Plain-English summary
C. O. Truxton is recalling Amitriptyline HCL Tablets, USP 50 mg, 100 count bottles. The product is manufactured for Qualitest Pharmaceuticals and distributed by Truxton, Inc. The recall is limited to Lot # C0260416A with an expiration date of 03/18. The NDC for the product is 0463-6352-10.
The recall was initiated because of a labeling issue described as a label mixup, meaning the tablets may be potentially mislabeled. This is an FDA Class II recall, which indicates a situation that might cause temporary or medically reversible adverse health consequences.
The affected product was distributed nationwide. Consumers and healthcare providers should check their inventory for this specific lot number and expiration date. If found, the product should be returned to the pharmacy or distributor for disposal or replacement.
The recalled product
- Product
- Amitriptyline HCL Tablets, USP 50 mg, 100 count bottles, Rx Only, Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811, Distributed by: Truxton, Inc. Bellmawr, NJ 08031, NDC: 0463-6352-10
- Manufacturer
- C. O. Truxton
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # C0260416A
- Exp. 03/18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by C. O. Truxton under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · C. O. Truxton
See all →- SevereC. O. Truxton Recalls Phenobarbital Tablets Due to Labeling Error
FDA (Drugs) · 2017-08-30
- CriticalPhenobarbital Tablets Recalled Due to Incorrect Strength Labeling
FDA (Drugs) · 2017-08-30
- ModerateC. O. Truxton Recalls Phenobarbital Tablets Due to Labeling Error
FDA (Drugs) · 2017-08-30
- ModerateC. O. Truxton Recalls Phenobarbital Tablets Due to Labeling Error
FDA (Drugs) · 2017-08-30
- ModeratePhenobarbital Tablets Recalled for Potential Labeling Errors
FDA (Drugs) · 2017-08-30
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereAidapak Recalls Nortriptyline Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Atomoxetine Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nortriptyline HCL Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- LowQualitest Recalls Ampicillin Capsules Due to Unapproved Labeling
FDA (Drugs) · 2015-08-26
- ModerateC. O. Truxton Recalls Doxycycline Hyclate Tablets Due to Wrong Bar Code
FDA (Drugs) · 2015-11-18
- ModerateSertraline HCL Tablets Recalled for Potential Labeling Errors
FDA (Drugs) · 2014-01-22